In the HPA database, we observed protein expressions of DBNDD1 in PCa patients using IHC staining, along with clinicopathological data such as patient ID, age, and gender in normal (Figure 4G) and tumor (Figure 4H) tissue samples. This evidence concerns the gene DBNDD1 and posterior cortical atrophy.